Manenti, 141 patient colchicine late treatment study: 76% lower mortality [p=0.005] and 44% improved recovery [p=0.05] https://c19p.org/manenti
copied to clipboard
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study
et al., PLOS ONE, doi:10.1371/journal.pone.0248276
IPTW retrospective 141 COVID-19 patients (83% hospitalized), 71 treated with colchicine and 70 matched control patients, showing lower mortality and faster recovery with treatment.
|
risk of death, 76.0% lower, HR 0.24, p = 0.005, treatment 71, control 70, adjusted per study, propensity score weighting.
|
|
risk of no recovery, 44.4% lower, RR 0.56, p = 0.048, treatment 71, control 70, adjusted per study, inverted to make RR<1 favor treatment, propensity score weighting.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Manenti et al., 24 Mar 2021, retrospective, Italy, peer-reviewed, 24 authors, study period 1 March, 2020 - 10 April, 2020.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.